Boardroom Alpha
Boardroom Alpha
DK · Current Report (Form 8-K) · Filed April 10, 2026

Delek US Holdings Inc — Current Report (Form 8-K)

Form
8-K
Filed
April 10, 2026
Period
Apr 9, 2026
Ticker
DK
Accession
0001193125-26-151245
Boardroom Alpha · Filing insights

Delek US increases Revolving Facility to $1.25B and extends maturity to 2031. It also reduces interest margins and expands borrowing flexibility.

About Delek US Holdings Inc
Market cap
$2.8B
1Y TSR
+128.7%
3Y TSR
+29.8%
Board grade
C+
Sector
Energy
CEO
Avigal Soreq
Last annual meeting: Apr 20, 2026 · View full Delek US Holdings Inc profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

April 9, 2026

Date of Report (Date of earliest event reported)

 

 

DELEK US HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38142   35-2581557
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

LOGO

 

310 Seven Springs Way, Suite 500   Brentwood   Tennessee    37027
(Address of Principal Executive)        (Zip Code)

(615) 771-6701

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $0.01 par value   DK   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01.

Entry into a Material Definitive Agreement.

On April 9, 2026, Delek US Holdings, Inc. (the “Company”) entered into Amendment No. 4 to Third Amended and Restated Credit Agreement (“Amendment No. 4”) among the Company, as borrower, certain wholly-owned subsidiaries of the Company, as guarantors, Wells Fargo Bank, National Association, as administrative agent and certain other lenders party thereto. Amendment No. 4 amends the existing Third Amended and Restated Credit Agreement, dated as of October 26, 2022 (as previously amended, the “Existing ABL Credit Agreement”, and as amended by Amendment No. 4, the “ABL Credit Agreement”), among the Company, certain subsidiaries of the Company, the Agent and the lenders and other persons from time to time party thereto.

Amendment No. 4, among other modifications, (i) increases the revolving loan commitments from $1,100.0 million to $1,250.0 million (the “Revolving Facility”), (ii) extends the maturity date of the Revolving Facility from October 26, 2027 to April 9, 2031 (subject to a springing maturity date that is 90 days prior to the maturity of the Company’s term loan credit facility if, on such date, the outstanding principal amount of the term loan exceeds $500.0 million), (iii) reduces the interest rate margins applicable to the Revolving Facility by 0.25% and (iv) amends certain thresholds for obligations under the Existing ABL Credit Agreement (including for negative covenants, events of default and borrowing base reporting requirements).

Amendment No. 4 also amends the incremental facility under the Revolving Facility to allow the Company to increase the available revolving borrowings by an aggregate amount not to exceed the greatest of (i) $750.0 million, (ii) 100% of EBITDA (as defined in the ABL Credit Agreement) as of the most recently ended fiscal quarter, and (iii) adjusted availability plus any suppressed availability under the ABL Credit Agreement, subject to the satisfaction of certain conditions under the ABL Credit Agreement.

The ABL Credit Agreement requires compliance with a minimum Fixed Charge Coverage Ratio of 1.00 to 1.00 when excess availability under the Revolving Facility falls below the greater of (x) $90.0 million and (y) 10% of the loan limit, and as amended pursuant to Amendment No. 4, such covenant will be tested on a quarterly basis.

The ABL Credit Agreement contains customary affirmative and negative covenants, including, among other things, limitations on indebtedness, liens, restricted payments, investments, dispositions of assets, and transactions with affiliates. The obligations under the ABL Credit Agreement are secured by first priority liens on substantially all of the tangible and intangible assets of the Company, including accounts, inventory, equipment, and other personal property, in each case subject to certain customary exceptions and excluded assets set forth in the ABL Credit Agreement and the related security documents.

The foregoing description of Amendment No. 4 does not purport to be complete and is qualified in its entirety by reference to the full text of Amendment No. 4, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 2.03.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information described in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

Number

   Description
10.1*    Amendment No. 4 to Third Amended and Restated Credit Agreement, dated as of April 9, 2026, by and among Delek US Holdings, Inc., certain subsidiaries of the Delek US Holdings, Inc., the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent for each member of the Lender Group and the Bank Product Providers.
104    Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

 

*

Certain schedules and similar attachments have been omitted. The Company agrees to furnish a supplemental copy of any omitted schedule or attachment to the Securities and Exchange Commission upon request.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: April 9, 2026     DELEK US HOLDINGS, INC.
     

/s/ Mark Hobbs

      Name:   Mark Hobbs
     

Title:

 

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Delek US Holdings Inc (DK)

Reference

Frequently asked questions

When did Delek US Holdings Inc file this 8-K?
Delek US Holdings Inc (DK) filed this Current Report (Form 8-K) with the SEC on April 10, 2026. The accession number assigned by EDGAR is 0001193125-26-151245.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Delek US increases Revolving Facility to $1.25B and extends maturity to 2031. It also reduces interest margins and expands borrowing flexibility. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Delek US Holdings Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Delek US Holdings Inc has filed under CIK 1694426, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer